Market open
Sartorius/€SRT3
08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX
About Sartorius
Sartorius AG, trading under the ticker symbol SRT3, is a global provider of laboratory and bioprocess technologies, offering products and services that cater to the needs of the biopharmaceutical and research industries. Founded in 1870 and headquartered in Göttingen, Germany, the company specializes in filtration, fermentation, fluid management, and laboratory products, supporting clients ranging from research facilities to large-scale biopharmaceutical manufacturers. Operating internationally, Sartorius is crucial in enabling the development and production of biotech medications and vaccines, solidifying its role as a crucial player in the life sciences and biotechnology sectors.
Ticker
€SRT3
Sector
Trading on
XETRA
Industry
Life Sciences Tools & Services
Headquarters
Employees
13,177
Website
Sartorius Metrics
BasicAdvanced
€15B
201.34
€1.22
1.04
€0.74
0.30%
Price and volume
Market cap
€15B
Beta
1.04
52-week high
€292.00
52-week low
€201.50
Average daily volume
94K
Dividend rate
€0.74
Financial strength
Current ratio
1.463
Quick ratio
0.837
Long term debt to equity
106.899
Total debt to equity
116.984
Dividend payout ratio (TTM)
60.36%
Interest coverage (TTM)
2.39%
Management effectiveness
Return on assets (TTM)
2.47%
Return on equity (TTM)
4.13%
Valuation
Price to earnings (TTM)
201.342
Price to revenue (TTM)
5.003
Price to book
5.48
Price to tangible book (TTM)
-5.6
Price to free cash flow (TTM)
29.865
Dividend yield (TTM)
0.30%
Forward dividend yield
0.30%
Growth
Revenue change (TTM)
-0.44%
Earnings per share change (TTM)
-59.48%
3-year revenue growth (CAGR)
-0.67%
3-year earnings per share growth (CAGR)
-36.07%
3-year dividend per share growth (CAGR)
-16.26%
What the Analysts think about Sartorius
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Sartorius stock.
Sartorius Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Sartorius Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe
Capital at risk
Market open
Upcoming events
Mar28
Sartorius
Dividend·Ex-dividend
Apr1
Sartorius
Dividend·Payment
€0.74
Per share
FAQs
What’s the current market cap for Sartorius stock?
Sartorius (SRT3) has a market cap of €15B as of March 19, 2025.
What is the P/E ratio for Sartorius stock?
The price to earnings (P/E) ratio for Sartorius (SRT3) stock is 201.34 as of March 19, 2025.
Does Sartorius stock pay dividends?
Yes, the Sartorius (SRT3) stock pays dividends to shareholders. As of March 19, 2025, the dividend rate is €0.74 and the yield is 0.3%. Sartorius has a payout ratio of 60.36% on a trailing twelve-month basis.
When is the next Sartorius dividend payment date?
The next Sartorius (SRT3) dividend payment is scheduled for April 01, 2025.
What is the beta indicator for Sartorius?
Sartorius (SRT3) has a beta rating of 1.04. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.